Dr. Kavita Patel, a medical contributor at NBC News and MSNBC, dives into the recent turmoil in the pharmaceutical industry, especially as Novo Nordisk's shares hit an 18-month low due to new Medicare price negotiations. She discusses the implications for the weight loss drug market and investor concerns about healthcare under changing political conditions. On another note, she speculates about Intel's stock surge driven by M&A rumors and what potential deals could mean for the tech sector.

Naomi Wolf, author and activist known for her work on public health issues, joins Dr. Kavita Patel, a former White House policy director, and Darren Beattie, a political commentator. They dissect Robert F. Kennedy Jr.'s controversial appointment as Secretary of Health and Human Services, discussing the impact on public trust and health policy. The conversation also touches on shifting political landscapes, the perils of digital currency, and the urgent need for transparency and accountability in health governance.

Dr. Kavita Patel, a former policy director in the Obama administration, shares her insights on the intersection of healthcare and market dynamics. Steve Leisman covers Fed Chair Jerome Powell's latest interest rate update, emphasizing a cautious economic outlook. The discussion also highlights Amazon's surprising move into telehealth, which is impacting Hims & Hers significantly. Both guests delve into the implications of political shifts on public health and how market reactions are shaped by monetary policy uncertainties.